BIOINF OÜ
- Registry code
- 11359595
- VAT number
- not VAT registered
- Address
- Harju maakond, Tallinn, Nõmme linnaosa, Põllu tn 28a-1, 11618
- Registered
- 08.03.2007 · 19 yrs
- Activity
- Research and experimental development on biotechnology 72111
- Capital
- 2 556 €
- t•••@h•••.comLog in to see
- Phone
- +372 5•• ••••Log in to see
Business Register 03.10.2026
Annual report 2025 not filed, deadline was 30.06.2026
Tegevuseta: käive ja töötajad puuduvad
Profit-135 k €2024 annual report
Labour taxes per quarter0 €Tax Board 2025 Q1
Cash16 726 €Cash 31.12.2024, annual report
Tax debt0 €Tax Board debtor list 03.10.2026
State taxes 12 months201 €Tax Board, last 4 quarters
Quick check
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2024)
- Not VAT registered
Stability
Follow companyNotification when something changesRatingA → BB
In tax debt0 days since 26.09.2026
Board and owners
2 persons
| Board 1 | ||
|---|---|---|
| Toomas Neuman3 companiesno tax debt | Personal ID ↗ | 08.03.2007 |
| Muud isikud 1 | ||
| Nasdaq CSD SE5342 companies434 with tax debt91 pankrotisOsade registripidajaOsad on Eesti väärtpaberite registris (Nasdaq CSD). See ei tähenda börsil noteerimist. | Personal ID ↗ | 27.09.2017 |
| Shareholders 1 | ||
| Omanikukonto: TOOMAS NEUMAN | 100,0% 2 556 € | 16.08.2023 |
| Beneficial owners 1 | ||
| Toomas Neuman3 companiesno tax debtotsene osalus | 24.09.2018 | |
Business Register open data
Quarterly taxes and revenue
2025 Q1
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2025 Q1 | — | 0 € | 50 € | — | |
| 2024 Q4 | — | 0 € | 1 € | — | |
| 2024 Q3 | — | 0 € | 100 € | — | |
| 2024 Q2 | — | 0 € | 50 € | — | |
| 2024 Q1 | 0 € | 212 € | 355 € | — | |
| 2023 Q4 | 0 € | 212 € | 383 € | — | |
| 2023 Q3 | 0 € | 424 € | 680 € | — | |
| 2023 Q2 | 0 € | 212 € | 340 € | — | |
| 2023 Q1 | 0 € | 318 € | 510 € | — | |
| 2022 Q4 | 0 € | 318 € | 510 € | — | |
| 2022 Q3 | 0 € | 318 € | 510 € | — | |
| 2022 Q2 | 0 € | 318 € | 510 € | — |
Näita kogu ajalugu (13 kvartalit)
| 2022 Q1 | 4 200 € | 318 € | 1 224 € | — |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | — | 0 € | ▼ 100% | 3 200 € | ▼ 71% | 11 000 € | |
| Profit | -135 k € | ▼ 17× | -8 094 € | ▼ 5% | -7 716 € | ▲ 66% | -22 719 € |
| Profit margin | — | — | -241,1% | -206,5% | |||
| Jaotamata kasum | 174 k € | ▼ 4% | 182 k € | ▼ 4% | 190 k € | ▼ 11% | 213 k € |
| Cash | 16 726 € | 0% | 16 672 € | 0% | 16 734 € | ▼ 3% | 17 316 € |
| Current assets | 16 726 € | ▼ 78% | 77 712 € | ▲ 1% | 77 094 € | ▼ 1% | 77 686 € |
| Põhivara | 80 960 € | ▼ 48% | 155 k € | 0% | 155 k € | 0% | 155 k € |
| Assets | 97 686 € | ▼ 58% | 232 k € | 0% | 232 k € | 0% | 232 k € |
| Current liabilities | 6 003 € | ▼ 89% | 55 186 € | ▲ 19% | 46 474 € | ▲ 18% | 39 350 € |
| Pikaajalised kohustised | 49 578 € | — | — | — | |||
| Total liabilities | 55 581 € | ▲ 1% | 55 186 € | ▲ 19% | 46 474 € | ▲ 18% | 39 350 € |
| Equity | 42 105 € | ▼ 76% | 177 k € | ▼ 4% | 185 k € | ▼ 4% | 193 k € |
| Tööjõukulud | 0 € | 0 € | 0 € | ▲ 100% | -29 415 € | ||
| Employees | 0 | 0 | 0 | ▼ 100% | 2 | ||
| Filed | 03.07.2025 | 09.12.2024 | 05.12.2024 | 09.09.2022 | |||
| Report | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ |
▲ kasv, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2022
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Research and experimental development on biotechnology main activity | 72111 | 3 200 € | 100% |
2022 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
No tax debt · Tax Board 03.10.2026
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
1 toetust
Toetuse saanud projektid
| Projekt | Meede | Periood | Toetus | Välja makstud |
|---|---|---|---|---|
| Eosinofiilide arengu blokeerimine: uus lähenemine allergiatega seotud eosinofiiliatele Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse, innovatsiooni edendamine | 10.09.2008 – 30.10.2008 | 12 694 € |
Riigi Tugiteenuste Keskus, toetatud projektid
Holdings in other companies
2
| Company | Kood | Osalus | Since | Revenue |
|---|---|---|---|---|
| dxlabs OÜ | 11503052 | 45,0% | 17.08.2023 | 39 533 € |
| IPDx Diagnostics OÜ | 14261017 | 63,5% | 29.08.2025 | 0 € |
Business Register
Companies linked via the board
60
Ericsson Eesti AktsiaseltsNasdaq CSD SE416,6 m €AAAS SEB PankNasdaq CSD SE405,8 m €AAAktsiaselts METAPRINTNasdaq CSD SE85,8 m €AAAElke Tallinn ASNasdaq CSD SE62,0 m €AAAosaühing NÕO LIHATÖÖSTUSNasdaq CSD SE48,3 m €AAAaktsiaselts ESTIKO - PLASTARNasdaq CSD SE48,2 m €AAAStockmann AktsiaseltsNasdaq CSD SE42,3 m €AAAktsiaselts BalbiinoNasdaq CSD SE29,5 m €AAAAktsiaselts Magnum VeterinaariaNasdaq CSD SE28,6 m €BBInterchemie Werken De Adelaar Eesti aktsiaseltsNasdaq CSD SE25,5 m €BBBosaühing SAVEKATENasdaq CSD SE25,2 m €AAASchneider Electric Eesti ASNasdaq CSD SE24,9 m €BAktsiaselts TopautoNasdaq CSD SE21,6 m €AAAktsiaselts Lincona KonsultNasdaq CSD SE19,2 m €AAAAS All Media EestiNasdaq CSD SE17,2 m €AAaktsiaselts PristisNasdaq CSD SE13,5 m €AAAAktsiaselts Viru ElektrikaubandusNasdaq CSD SE10,6 m €AAAktsiaselts STANDARDNasdaq CSD SE10,6 m €AHorticom OÜNasdaq CSD SE10,5 m €AAAaktsiaselts LTTNasdaq CSD SE10,2 m €AAAMotoral Eesti AktsiaseltsNasdaq CSD SE8,6 m €AAktsiaselts Silmani ElekterNasdaq CSD SE8,0 m €AAmari Metals OÜNasdaq CSD SE7,2 m €Aaktsiaselts "Rauameister"Nasdaq CSD SE6,8 m €AAAktsiaselts "Erimell"Nasdaq CSD SE6,4 m €AAAAktsiaselts Taastusravikeskus ViikingNasdaq CSD SE5,8 m €AAAaktsiaselts IKODORNasdaq CSD SE4,9 m €AAAktsiaselts ANTAARESNasdaq CSD SE4,7 m €AACaverion Eesti ASNasdaq CSD SE4,6 m €AAktsiaselts Kiviõli KaubahoovNasdaq CSD SE4,4 m €AAAktsiaselts Metsaküla PiimNasdaq CSD SE3,9 m €AAAOÜ Eagle VisionNasdaq CSD SE3,6 m €AAaktsiaselts VÕRU VESINasdaq CSD SE3,4 m €AAAEF Production OÜNasdaq CSD SE3,3 m €AAaktsiaselts CISTANasdaq CSD SE2,6 m €AAABasseinitehnika OÜNasdaq CSD SE2,5 m €AAARTT AktsiaseltsNasdaq CSD SE2,1 m €AAAAS Remedium Kalamaja ApteekNasdaq CSD SE1,7 m €AAaktsiaselts ESTIKONasdaq CSD SE1,6 m €AAAVERSKA MINERAALVEE osaühingNasdaq CSD SE1,5 m €AAAAktsiaselts Ekspress GruppNasdaq CSD SE1,4 m €AOsaühing AllfilmNasdaq CSD SE1,2 m €AAOsaühing Kallaste KalurNasdaq CSD SE1,2 m €AAALEKON PROPERTY ASNasdaq CSD SE1,2 m €AAAosaühing KediivNasdaq CSD SE1,1 m €AAAAktsiaselts FotoluksNasdaq CSD SE1,1 m €BBBAuto ID osaühingNasdaq CSD SE810 k €AAAAktsiaselts MihkliNasdaq CSD SE475 k €AAAS Tolaram InvestmentsNasdaq CSD SE380 k €AAAktsiaselts YearNasdaq CSD SE132 k €CRaisio Eesti AktsiaseltsNasdaq CSD SE120 k €ADeden-Invest AktsiaseltsNasdaq CSD SE51 638 €AOsaühing Pelguranna PandimajaNasdaq CSD SE33 179 €Aosaühing ToplexNasdaq CSD SE14 918 €AKatus ASNasdaq CSD SE13 588 €AOsaühing NIKOLLONasdaq CSD SE6 140 €Cosaühing ILMATSALU KALANasdaq CSD SE4 426 €Aaktsiaselts FaabulaNasdaq CSD SE0 €BBBAktsiaselts TalveaedNasdaq CSD SE · Likvideerimisel0 €CAktsiaselts SpratfilNasdaq CSD SE · Bankrupt0 €C
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Research and experimental development on biotechnology
4
| # | Company | Revenue |
|---|---|---|
| 1 | GeneCode AS | 1,1 m € |
| 2 | SMOBYA OÜ | 8 413 € |
| 3 | Tiit Vaasna | 1 514 € |
| 4 | Follistic OÜ | 152 € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
14
| Date | Liik | Sisu |
|---|---|---|
| 18.09.2026 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 04.11.2024 | Aruandetrahvimäärus | |
| 12.09.2024 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 02.05.2024 | Korduv aruandetrahvimäärus | |
| 24.01.2024 | Aruandetrahvimäärus | |
| 26.09.2023 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 17.01.2018 | Kanne | Muutmiskanne |
| 30.11.2017 | Kanne | Muutmiskanne |
| 27.09.2017 | Kanne | Muutmiskanne |
| 14.09.2016 | Kanne | Muutmiskanne |
| 02.02.2012 | Kanne | Muutmiskanne |
| 28.12.2011 | Eitav kandemäärus: puudused kõrvaldamata | Muutmiskanne |
| 17.02.2009 | Märge osade või aktsiate registreerituse kohta EVK-s | Märkus |
| 08.03.2007 | Kanne | Esmakanne |